跳至主要内容
临床试验/IRCT20171112037420N1
IRCT20171112037420N1已完成未知

Comparison of Levofloxacin-containing quadruple therapy versus standard triple therapy as the first line for the helicobacter pylori eradication

Sabzevar University of Medical Sciences0 个研究点目标入组 98 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
98

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients who are performed upper endoscopy and have positive rapid urease test.
  • Patients with over 18 years of age

排除标准

  • Allergy to medicent which used this study
  • Patients were treated helicobacter pylori eradication previously.
  • lack of willingness to continue the period of treatment
  • lack of willingness to complete the period of treatment

研究者

发起方
Sabzevar University of Medical Sciences

相似试验

Comparison of Levofloxacin based quadruple therapy... | 临床试验